Search Within

Mark E Robson

  1. "2017"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (16)
Groups
  1. Breast Medicine Service (47)
  2. Department of Medicine (47)
  3. Population Sciences Research Program (47)
  4. Solid Tumor Oncology Division (47)
  5. Survivorship Research (47)
  6. GSK Faculty (25)

More Groups

People
  1. Kenneth Offit (17)
  2. David Hyman (8)
  3. Michael Berger (8)
  4. Vijai Joseph (8)
  5. Diana Mandelker (7)
  6. Marc Ladanyi (7)

More People

Years
  1. 2017 (47)
Publications
  1. Journal of Clinical Oncology (10)
  2. Breast Cancer Research and Treatment (4)
  3. Cancer Research (4)
  4. Annals of Oncology (2)
  5. JCO Precision Oncology (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (5)
  3. Springer (5)
  4. Oxford University Press (4)
  5. Nature Publishing Group (3)
  6. American Medical Association (2)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Decision-making preferences about secondary germline findings that arise from tumor genomic profiling among patients with advanced cancers
    Journal Article

    Hamilton, J. G.; Shuk, E.; Garzon, M. G.; Rodríguez, V. M.; Westerman, J.; Hay, J. L.; Offit, K.; Robson, M. E.
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Determining the prevalence of germline BAP1 mutations in malignant mesothelioma (MM)
    Meeting Abstract

    Zauderer, M. G.; DuBoff, M. A.; Siegel, B.; Robson, M. E.; Arnold, A. G.; Berliner, J.; Fleischut, M. H.; Mandelker, D.; Ladanyi, M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Final results of a phase 2 study of talazoparib (TALA) following platinum or multiple cytotoxic regimens in advanced breast cancer patients (pts) with germline BRCA1/2 mutations (ABRAZO)
    Meeting Abstract

    Turner, N. C.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E. M.; Mina, L. A.; Gelpi, J. B.; Fasching, P. A.; Hurvitz, S. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • OlympiAD: Phase III trial of olaparib monotherapy versus chemotherapy for patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm)
    Meeting Abstract

    Robson, M. E.; Im, S. A.; Senkus, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N. M.; Armstrong, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical characterization of pancreatic ductal adenocarcinomas (PDAC) with mismatch repair (MMR) gene mutations
    Meeting Abstract

    Hu, Z. I.; Varghese, A. M.; Shia, J.; Zervoudakis, A.; Lowery, M. A.; Yu, K. H.; Chalasani, S. B.; Robson, M. E.; Stadler, Z. K.; Caron, P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Discovery and prevalence of cancer-susceptibility germline mutations (Mts) in patients (Pts) with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Carlo, M. I.; Mukherjee, S.; Kemel, Y.; Zhang, L.; Mandelker, D.; Vijai, J.; Coskey, D. T.; Pradhan, N.; Hyman, D. M.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Germline BRCA2 mutations detected in pediatric sequencing studies impact parents' evaluation and care
    Journal Article

    Walsh, M. F.; Kennedy, J.; Harlan, M.; Kentsis, A.; Shukla, N.; Musinsky, J.; Roberts, S.; Kung, A. L.; Robson, M.; Kushner, B. H.; more...
    Cold Spring Harbor Molecular Case Studies (2017)

    Fulltext@MSK | Save